An Expert Perspective on Phosphate Dysregulation With a Focus on Chronic Hypophosphatemia
dc.contributor.author | Aljuraibah, Fahad | |
dc.contributor.author | Bacchetta, Justine | |
dc.contributor.author | Brandi, Maria Luisa | |
dc.contributor.author | Florenzano, Pablo | |
dc.contributor.author | Javaid, Muhammad K. | |
dc.contributor.author | Makitie, Outimaija | |
dc.contributor.author | Raimann, Adalbert | |
dc.contributor.author | Rodriguez, Mariano | |
dc.contributor.author | Siggelkow, Heide | |
dc.contributor.author | Tiosano, Dov | |
dc.contributor.author | Vervloet, Marc | |
dc.contributor.author | Wagner, Carsten A. | |
dc.contributor.authoraffiliation | [Aljuraibah, Fahad] King Saud Bin Abdulaziz Univ Hlth Sci, Coll Med, Riyadh, Saudi Arabia | |
dc.contributor.authoraffiliation | [Bacchetta, Justine] Hop Femme Mere Enfant, INSERM1033 Res Unit, Bron, France | |
dc.contributor.authoraffiliation | [Brandi, Maria Luisa] Univ Florence, Florence, Italy | |
dc.contributor.authoraffiliation | [Florenzano, Pablo] Pontificia Univ Catolica Chile, Santiago, Chile | |
dc.contributor.authoraffiliation | [Javaid, Muhammad K.] Univ Oxford, Oxford, England | |
dc.contributor.authoraffiliation | [Makitie, Outimaija] Univ Helsinki, Childrens Hosp, Helsinki, Finland | |
dc.contributor.authoraffiliation | [Makitie, Outimaija] Helsinki Univ Hosp, Helsinki, Finland | |
dc.contributor.authoraffiliation | [Raimann, Adalbert] Med Univ Vienna, Vienna, Austria | |
dc.contributor.authoraffiliation | [Rodriguez, Mariano] Hosp Univ Reina Sofia, IMIBIC, Cordoba, Spain | |
dc.contributor.authoraffiliation | [Siggelkow, Heide] Univ Med Ctr, Gottingen, Germany | |
dc.contributor.authoraffiliation | [Tiosano, Dov] Rambam Med Ctr, Haifa, Israel | |
dc.contributor.authoraffiliation | [Vervloet, Marc] Univ Amsterdam, Med Ctr, Amsterdam, Netherlands | |
dc.contributor.authoraffiliation | [Wagner, Carsten A.] Univ Zurich, Zurich, Switzerland | |
dc.contributor.authoraffiliation | [Wagner, Carsten A.] Swiss Natl Ctr Competence Res NCCR Kidney CH, Zurich, Switzerland | |
dc.contributor.funder | Projekt DEAL | |
dc.date.accessioned | 2025-01-07T13:24:29Z | |
dc.date.available | 2025-01-07T13:24:29Z | |
dc.date.issued | 2021-12-23 | |
dc.description.abstract | Because of their rarity, diseases characterized by chronic hypophosphatemia can be underrecognized and suboptimally managed, resulting in poor clinical outcomes. Moreover, serum phosphate may not be measured routinely in primary care practice. Authors participated in several working sessions to advance the understanding of phosphate homeostasis and the causes, consequences, and clinical implications of chronic hypophosphatemia. Phosphate levels are regulated from birth to adulthood. Dysregulation of phosphate homeostasis can result in hypophosphatemia, which becomes chronic if phosphate levels cannot be normalized. Chronic hypophosphatemia may be underrecognized as serum phosphate measurement is not always part of routine analysis in the primary care setting and results might be misinterpreted, for instance, due to age-specific differences not being accounted for and circadian variations. Clinical consequences of chronic hypophosphatemia involve disordered endocrine regulation, affect multiple organ systems, and vary depending on patient age and the underlying disorder. Signs and symptoms of chronic hypophosphatemic diseases that manifest during childhood or adolescence persist into adulthood if the disease is inadequately managed, resulting in an accumulation of clinical deficits and a progressive, debilitating impact on quality of life. Early identification and diagnosis of patients with chronic hypophosphatemia is crucial, and clinical management should be started as soon as possible to maximize the likelihood of improving health outcomes. Furthermore, in the absence of a universally accepted description for "chronic hypophosphatemia," a definition is proposed here that aims to raise awareness of these diseases, facilitate diagnosis, and guide optimal phosphate management strategies by improving monitoring and assessment of patient response to treatment. (c) 2021 The Authors. Journal of Bone and Mineral Research published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research (ASBMR). | |
dc.identifier.doi | 10.1002/jbmr.4486 | |
dc.identifier.essn | 1523-4681 | |
dc.identifier.issn | 0884-0431 | |
dc.identifier.pmid | 34870347 | |
dc.identifier.unpaywallURL | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jbmr.4486 | |
dc.identifier.uri | https://hdl.handle.net/10668/25487 | |
dc.identifier.wosID | 733646600001 | |
dc.issue.number | 1 | |
dc.journal.title | Journal of bone and mineral research | |
dc.journal.titleabbreviation | J. bone miner. res. | |
dc.language.iso | en | |
dc.organization | SAS - Hospital Universitario Reina Sofía | |
dc.organization | Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC) | |
dc.page.number | 12-20 | |
dc.publisher | Wiley | |
dc.rights | Attribution-NonCommercial 4.0 International | |
dc.rights.accessRights | open access | |
dc.rights.uri | http://creativecommons.org/licenses/by-nc/4.0/ | |
dc.subject | PHOSPHATE HOMEOSTASIS | |
dc.subject | HYPOPHOSPHATEMIA | |
dc.subject | OSTEOMALACIA AND RICKETS | |
dc.subject | PARATHYROID HORMONE | |
dc.subject | VITAMIN D | |
dc.subject | FIBROBLAST GROWTH FACTOR 23 | |
dc.subject | X-linked hypophosphatemia | |
dc.subject | Serum phosphorus | |
dc.subject | Metabolism | |
dc.subject | Rickets | |
dc.subject | Growth | |
dc.subject | Adults | |
dc.subject | Abnormalities | |
dc.subject | Mechanisms | |
dc.subject | Experience | |
dc.subject | Management | |
dc.title | An Expert Perspective on Phosphate Dysregulation With a Focus on Chronic Hypophosphatemia | |
dc.type | research article | |
dc.type.hasVersion | VoR | |
dc.volume.number | 37 | |
dc.wostype | Article |